Overview

Efficacy of Ciclesonide Versus Placebo Administered Either as Once Daily or Twice Daily in Patients Treated Previously With an Inhaled Corticosteroid

Status:
Completed

Trial end date:
2006-02-01

Target enrollment:

Participant gender:

Summary

To investigate the efficacy of ciclesonide MDI either as once daily or a twice daily regimen in patients with mild to moderate asthma, who have previously been treated with an inhaled corticosteroid.

Phase:

Phase 3

Details

Lead Sponsor:

Sanofi

Treatments:

Ciclesonide